An open-access resource helping scientists to accelerate ALS drug discovery by fostering collaboration, reporting the latest news & sharing research tools.
Could a cancer drug targeting PARPs be repurposed as a treatment for #ALS#MND? A growing number of studies @PennMedicine suggest its a possibility. https://t.co/lsAUXXmWqY @LeeanneMcgurk@ShorterLab
Looking to learn more about #ALS#MND but do not have access to a science or medical library? Check out our updated list of open-access reviews of the disease https://t.co/hqLhXqazBJ
Could disease heterogeneity be due to the "shapeshifting" nature of #TDP-43 pathology? A new #FTD study @NatureNeuro suggests its a possibility. https://t.co/fJxcSB2rQS #ALS#MND
Looking to present your latest findings in #ALS#MND at an upcoming scientific conference? Check out our 2019 meeting calendar! https://t.co/VM3Zse7q5E #ALS#MND
Are you aiming to facilitate clinical testing of potential #ALS#MND therapies by developing strategies to reduce disease heterogeneity? Check out this upcoming funding call @JPNDeurope to support your research https://t.co/BtYyqmIacI via @The_MRC
Could an emerging test help detect and monitor cognitive decline in neurodegenerative diseases? A new study @JAMANeuro suggests that its a possibility https://t.co/qTj2EgEa8t #FTD#ALS
Researchers @MGHNeurology detect glial activation in the spinal cord in addition to the brain in people with #ALS, a key step in developing an imaging-based tool to help evaluate potential immunotherapies in #clinicaltrials#alssymp
Excellent session on #ALS#MND#clinicaltrials today #alssymp moderated by @MeritCudkowicz @LeonardvandBerg -learning from #oncology re: platform trials. Time to bring about a paradigm shift in ALS trials to make the drug development process faster and more efficient
Wondering how genotyping might help facilitate testing of potential therapies for #ALS#MND in the clinic? Check out this article from our archives https://t.co/bLqimD6B5S #UNC13A#C21#alssymp
Learn more about emerging "organ on chip" models that aim to facilitate the development of treatments for neurodegenerative diseases including #ALS by optimizing their ability to enter the CNS https://t.co/sUSs8IeKlW #alssymp#C4
Wondering how changes in the gut could contribute to neurodegenerative diseases including #ALS? Check out this article from our archives https://t.co/hhR8IqAYgn #microbiome#C2#alssymp
Missed the first day of the #stemcell @CellSymposia in Los Angeles, California yesterday? Check out this article from our archives https://t.co/2taojssWyL #ALS#MND
Researchers debate a new strategy to tackle #ALS#MND targeting TDP-43 pathology at the 5th RNA Metabolism in Neurological Disease Conference in San Diego https://t.co/vY1dkZgHyo #stathmin2#ASO#SfN18